Skip to main content

Peer Review reports

From: Effect of empagliflozin on cardiac remodelling in South Asian and non-South Asian individuals: insights from the EMPA-HEART CardioLink-6 randomised clinical trial

Original Submission
3 May 2023 Submitted Original manuscript
20 Jun 2023 Reviewed Reviewer Report - Joaquim Barreto
22 Jun 2023 Reviewed Reviewer Report - Ashish Kumar
10 Jul 2023 Author responded Author comments - Subodh Verma
18 Jul 2023 Author responded Author comments - Subodh Verma
Resubmission - Version 2
10 Jul 2023 Submitted Manuscript version 2
31 Jul 2023 Author responded Author comments - Subodh Verma
Resubmission - Version 3
31 Jul 2023 Submitted Manuscript version 3
8 Aug 2023 Author responded Author comments - Subodh Verma
Resubmission - Version 4
8 Aug 2023 Submitted Manuscript version 4
11 Aug 2023 Author responded Author comments - Subodh Verma
Resubmission - Version 5
11 Aug 2023 Submitted Manuscript version 5
22 Aug 2023 Reviewed Reviewer Report - Joaquim Barreto
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
6 Oct 2023 Editorially accepted
15 Nov 2023 Article published 10.1186/s12872-023-03549-5

You can find further information about peer review here.

Back to article page